As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Illumina will likely underperform.
The median price of Illumina for the period between Wed, Apr 24, 2013 and Fri, May 24, 2013 is 67.16 with a coefficient of variation of 5.12. The daily time series for the period is distributed with a sample standard deviation of 3.46, arithmetic mean of 67.56, and mean deviation of 3.03. The Stock received substential amount of media coverage during this period.
Illumina Inc [ILMN] is traded on NASDAQ in USA. It is located in San Diego, CA and employs 2,400 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 8.7 B. Illumina Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 124.38 M outstanding shares of which 28.58 M shares are currently shorted by private and institutional investors with about 30.3 trading days to cover.
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the AsiaPacific, the Middle East, and South Africa. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory